Ablation centration in laser in situ keratomileusis for hyperopia: comparison of VISX S3 ActiveTrak and VISX S2.
To compare ablation centration and outcome measurements in laser in situ keratomileusis (LASIK) for hyperopia using the pupil-tracking VISX S3 ActiveTrak or the nontracking VISX S2 excimer laser. In a retrospective study, 49 consecutively treated hyperopic eyes (32 patients) that had LASIK by the VISX StarS3 ActiveTrak were compared to 49 control-matched eyes treated with the VISX StarS2 without pupil-tracking. Primary outcome variables including ablation centration, uncorrected visual acuity, best spectacle-corrected visual acuity, manifest refraction, complications, and induced cylinder analyzed by vector analysis were evaluated 3 months postoperatively. Hyperopic sphere ranged between plano and +5.50 D and cylinder between 0 and +2.75 D. Ninety-five of 98 eyes (96.9%) were available for analysis at 3 months. Of these 95, 52 eyes could be used for analysis of ablation centration. Mean decentration of the ablation zone from the entrance pupil was 0.30 +/- 0.20 mm in tracked eyes (n=31) and 0.41 +/- 0.39 mm in nontracked eyes (n=21), P=.17. Two eyes (6.5%) in the tracked group were significantly decentered between 0.5 and 1 mm from the pupil center. In the nontracked group, decentration was between 0.5 and 1 mm in one eye (4.8%) and greater than 1 mm in two eyes (9.5%). Comparable ablation centration in LASIK for hyperopia was achieved between actively-tracked and nontracked eyes. Decentrations (greater than 1 mm) were not seen with a tracking system in this study. Visual and refractive results were similar between the VISX StarS3 ActiveTrak and VISX StarS2 laser systems.